CANCERFORSKNINGSFONDEN AF 1989 has a total of 11 patent applications. Its first patent ever was published in 1990. It filed its patents most often in EPO (European Patent Office), Japan and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CANCERFORSKNINGSFONDET AF 1989, DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS and SEC DEP FOR ENVIRONMENT FOOD &.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Japan | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Analysing materials | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Ellis Vincent | 9 |
#2 | Pyke Charles | 7 |
#3 | Danoe Keld | 6 |
#4 | Behrendt Niels | 6 |
#5 | Ploug Michael | 6 |
#6 | Roenne Ebbe | 4 |
#7 | Bruenner Nils | 4 |
#8 | Stephens Ross W | 4 |
#9 | Dano Keld | 4 |
#10 | Masucci Maria Teresa | 3 |
Publication | Filing date | Title |
---|---|---|
JP2003021632A | Antibody against urokinase receptor and its use | |
WO0001802A2 | Peptide antagonists of the human urokinase receptor and method for selecting them |